A recent study highlights the efficacy and safety of iron infusions during the third trimester of pregnancy, showing that they are significantly more effective than traditional iron tablets in combating anemia in pregnant women. This research, a collaboration between WEHI in Australia and the Training Research Unit of Excellence in Malawi, demonstrates that a single iron infusion can markedly improve maternal iron levels, which is crucial for the health of both mother and baby.
Iron deficiency is a prevalent issue globally, affecting approximately 37% of pregnant women and leading to complications such as preterm birth and low birth weight. The trial involved 590 women in Malawi, revealing a lower prevalence of anemia among those who received infusions compared to those on oral supplements. The findings support the potential for iron infusions to boost iron stores even postpartum.
The study advocates for revising global maternal care guidelines to include intravenous iron, particularly in resource-limited settings, where effective implementation is feasible. The research aims to influence future recommendations from the World Health Organization, transitioning from oral iron tablets to infusions as a standard preventive strategy against maternal anemia.
